Abstract
Given the circumstance of limited resources, comparative effectiveness research (CER) and cost-effectiveness analysis (CEA) became a popular and important tool in medicine, particular for the evaluation of novel diagnostic test strategies including cardiac CT. Several randomized controlled trials and CEA have been performed regarding the evaluation of patients with stable chest pain and/or with suspicion of acute coronary syndrome. Overall, the results suggest that cardiac CT – as an anatomical test – may serve as a cost-effective gatekeeper with an incremental cost-effectiveness ratio (ICER) below the willingness-to-pay threshold. However, these findings are based on many assumptions and particularly sensitive to the pretest probability for coronary artery disease. Further, based on the example of CEA regarding reporting of incidental findings in cardiac CT, it will be discussed that decision-making is not just a function of an economical evaluation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
OECD.Stat, Health expenditure and financing. Joint OECD, EUROSTAT and WHO Health Accounts SHA Questionnaires (JHAQ). https://stats.oecd.org/index.aspx?DataSetCode=SHA
US Centers for Medicare & Medicaid Services National Health Expenditures 2015 Highlights. https://ccf.georgetown.edu/wp-content/uploads/pdfs/highlights.pdf
Goehler A, Gazelle GS. Examining the use of comparative and cost-effectiveness analyses in radiology. AJR Am J Roentgenol. 2014;203(5):939–44.
Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5(1):1–30.
Hanmer J, et al. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Mak. 2006;26(4):391–400.
Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716–21.
Marseille E, et al. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015;93:118–24.
Russell LB, et al. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. JAMA. 1996;276(14):1172–7.
Hoffmann U, et al. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med. 2012;367(4):299–308.
Litt HI, et al. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med. 2012;366(15):1393–403.
Khare RK, et al. Sixty-four-slice computed tomography of the coronary arteries: cost-effectiveness analysis of patients presenting to the emergency department with low-risk chest pain. Acad Emerg Med. 2008;15(7):623–32.
Ladapo JA, et al. Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR Am J Roentgenol. 2008;191(2):455–63.
Douglas PS, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372(14):1291–300.
Investigators, S-H. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet. 2015;385(9985):2383–91.
Min JK, et al. Coronary CT angiography versus myocardial perfusion imaging for near-term quality of life, cost and radiation exposure: a prospective multicenter randomized pilot trial. J Cardiovasc Comput Tomogr. 2012;6(4):274–83.
Fordyce CB, Newby DE, Douglas PS. Diagnostic strategies for the evaluation of chest pain: clinical implications from SCOT-HEART and PROMISE. J Am Coll Cardiol. 2016;67(7):843–52.
van Waardhuizen CN, et al. Diagnostic performance and comparative cost-effectiveness of non-invasive imaging tests in patients presenting with chronic stable chest pain with suspected coronary artery disease: a systematic overview. Curr Cardiol Rep. 2014;16(10):537.
Genders TS, et al. The optimal imaging strategy for patients with stable chest pain: a cost-effectiveness analysis. Ann Intern Med. 2015;162(7):474–84.
Ladapo JA, et al. Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol. 2009;54(25):2409–22.
Min JK, et al. Costs and clinical outcomes in individuals without known coronary artery disease undergoing coronary computed tomographic angiography from an analysis of Medicare category III transaction codes. Am J Cardiol. 2008;102(6):672–8.
Hachamovitch R, et al. Patient management after noninvasive cardiac imaging results from SPARC (study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol. 2012;59(5):462–74.
Genders TS, et al. Coronary computed tomography versus exercise testing in patients with stable chest pain: comparative effectiveness and costs. Int J Cardiol. 2013;167(4):1268–75.
Genders TS, et al. CT coronary angiography in patients suspected of having coronary artery disease: decision making from various perspectives in the face of uncertainty. Radiology. 2009;253(3):734–44.
Dorenkamp M, et al. Direct costs and cost-effectiveness of dual-source computed tomography and invasive coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease. Heart. 2012;98(6):460–7.
Moss AJ, et al. The updated NICE guidelines: cardiac CT as the first-line test for coronary artery disease. Curr Cardiovasc Imaging Rep. 2017;10(5):15.
Goehler A, et al. Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease. Circulation. 2014;130(8):668–75.
Lu MT, et al. Lung cancer screening eligibility in the community: cardiovascular risk factors, coronary artery calcification, and cardiovascular events. Circulation. 2016;134(12):897–9.
Kreisz FP, et al. The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease in patients otherwise referred to invasive coronary angiography. Heart Lung Circ. 2009;18(3):200–7.
Min JK, et al. Cost-effectiveness of coronary CT angiography versus myocardial perfusion SPECT for evaluation of patients with chest pain and no known coronary artery disease. Radiology. 2010;254(3):801–8.
Meyer M, et al. Cost-effectiveness of substituting dual-energy CT for SPECT in the assessment of myocardial perfusion for the workup of coronary artery disease. Eur J Radiol. 2012;81(12):3719–25.
Genders TS, et al. Coronary computed tomography versus exercise testing in patients with stable chest pain: comparative effectiveness and costs. Int J Cardiol. 2013;167(4):1268–75.
Agus AM, et al. The cost-effectiveness of cardiac computed tomography for patients with stable chest pain. Heart. 2016;102(5):356–62.
Bertoldi EG, et al. Long-term cost-effectiveness of diagnostic tests for assessing stable chest pain: modeled analysis of anatomical and functional strategies. Clin Cardiol. 2016;39(5):249–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Humana Press
About this chapter
Cite this chapter
Schlett, C.L. (2019). Cardiac CT: Comparative Cost-Effectiveness. In: Schoepf, U. (eds) CT of the Heart. Contemporary Medical Imaging. Humana, Totowa, NJ. https://doi.org/10.1007/978-1-60327-237-7_52
Download citation
DOI: https://doi.org/10.1007/978-1-60327-237-7_52
Published:
Publisher Name: Humana, Totowa, NJ
Print ISBN: 978-1-60327-236-0
Online ISBN: 978-1-60327-237-7
eBook Packages: MedicineMedicine (R0)